Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multiple sclerosis: summary of NICE guidance.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Towards establishing MS prevalence in Latin America and the Caribbean.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
JC viremia in natalizumab-treated patients with multiple sclerosis.
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Prolongation of survival of rat cardiac allografts by T cell vaccination.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Pediatric multiple sclerosis in Venezuela.
Is multiple sclerosis an autoimmune disease?
Enrollment complete for cannabinoid MS study
Simvastatin: a review.
The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation.
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
Psychiatric disorders in neurology.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Tumor-like multiple sclerosis.
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis
Laquinimod CHMP/EMA opinion
Pages
« first
‹ previous
…
144
145
146
147
148
149
150
151
152
…
next ›
last »
